Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Year-over-year debt growth rate
Percentile
P10
Near historical low
vs 3Y Ago
-21.4x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -14.61% |
| Q3 2025 | -48.65% |
| Q2 2025 | -3.68% |
| Q1 2025 | -15.08% |
| Q4 2024 | 2.36% |
| Q3 2024 | 87.59% |
| Q2 2024 | 13.57% |
| Q1 2024 | 1.93% |
| Q4 2023 | 2.29% |
| Q3 2023 | 363.53% |
| Q2 2023 | -0.06% |
| Q1 2023 | 0.79% |
| Q4 2022 | 0.68% |
| Q3 2022 | 0.57% |
| Q2 2022 | 216.75% |
| Q1 2022 | 1.16% |
| Q4 2021 | -0.90% |
| Q3 2021 | 5.80% |
| Q2 2021 | 1.45% |
| Q1 2021 | 14.05% |
| Q4 2020 | -1.28% |
| Q3 2020 | -1.09% |
| Q2 2020 | 43.75% |
| Q1 2020 | 0.19% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | -100.00% |
| Q3 2018 | -2.25% |
| Q2 2018 | -2.16% |
| Q1 2018 | -2.08% |
| Q4 2017 | -2.00% |
| Q3 2017 | -1.93% |
| Q2 2017 | -1.86% |
| Q1 2017 | -1.80% |
| Q4 2016 | -1.73% |
| Q3 2016 | -17.92% |
| Q2 2016 | 411.26% |
| Q1 2016 | -7.71% |